Live Breaking News & Updates on Jiafu Ji

Stay updated with breaking news from Jiafu ji. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Combo Therapy Prolongs Survival in Gastric Cancer Patients

The overall survival advantage held regardless of PD-L1 status in patients receiving the first-line combination of cadonilimab and standard chemotherapy. ....

United States , Jiafu Ji , American Association For Cancer Research , Drug Administration , Institute For Cancer Research , University Cancer Hospital , American Association , Cancer Research , Peking University Cancer Hospital , Beijing Institute , New Treatment Paradigm , Advanced Gastric , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Combination Chemotherapy , Gastric Cancer , Alignant Stomach Neoplasm , Stomach Cancer , Gastric Carcinoma , Alignant Neoplasia , Alignant Neoplasm , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents ,

Cadonilimab Plus Chemo "Could Be New Standard Care" for Advanced Gastric, GEJ Cancer

Phase 3 data suggest that adding cadonilimab to chemotherapy can improve outcomes in patients with advanced gastric/GEJ cancer. ....

Jiafu Ji , United Family Healthcare ,

Cadomilimab Plus Oxaliplatin and Capecitabine Leads to Survival Benefit in Gastric/GEJ Cancer

Cadomilimab plus oxaliplatin and capecitabine leads to survival benefit in gastric/GEJ adenocarcinoma, regardless of PD-L1 expression. ....

San Diego , United States , Jiafu Ji , University Hospital , China National Medical Products Administration , Akeso Inc , Peking University Hospital , Enrollment Criteria , Future Directions With ,

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Jiafu Ji , American Association For Cancer Research , American Association , Cancer Research , Gastrointestinal Cancer Center , Peking University Cancer Hospital ,

Novel Treatment Shows Early Promise for Gastric Cancer

A novel antibody acting on both PD-1 and CTLA4 has shown activity in first-line treatment of gastric and gastroesophageal junction cancer. ....

Akeso Biopharma , Jiafu Ji , Katherine Bever , Johns Hopkins University , University Cancer Hospital , Institute Gastrointestinal Cancer Center , Cancers Symposium , Peking University Cancer Hospital , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Gastric Cancer , Alignant Stomach Neoplasm , Alignant Neoplasia , Cervical Cancer , Alignant Cervix Neoplasm , Gastrointestinal Malignancy , I Malignancy , Clinical Research , Clinical Trials , Linical Studies , Combination Chemotherapy ,